rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2003-9-11
|
pubmed:abstractText |
Microvascular dysfunction, reflected by an inadequate increase in myocardial blood flow in response to dipyridamole infusion, is a recognized feature of hypertrophic cardiomyopathy. Its long-term effect on the prognosis is unknown. We prospectively evaluated a cohort of patients with hypertrophic cardiomyopathy after they had undergone quantitative assessment of myocardial blood flow by positron-emission tomography (PET).
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1533-4406
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2003 Massachusetts Medical Society
|
pubmed:issnType |
Electronic
|
pubmed:day |
11
|
pubmed:volume |
349
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1027-35
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12968086-Adult,
pubmed-meshheading:12968086-Analysis of Variance,
pubmed-meshheading:12968086-Cardiomyopathy, Hypertrophic,
pubmed-meshheading:12968086-Cohort Studies,
pubmed-meshheading:12968086-Coronary Circulation,
pubmed-meshheading:12968086-Dipyridamole,
pubmed-meshheading:12968086-Female,
pubmed-meshheading:12968086-Follow-Up Studies,
pubmed-meshheading:12968086-Humans,
pubmed-meshheading:12968086-Male,
pubmed-meshheading:12968086-Microcirculation,
pubmed-meshheading:12968086-Middle Aged,
pubmed-meshheading:12968086-Prognosis,
pubmed-meshheading:12968086-Proportional Hazards Models,
pubmed-meshheading:12968086-ROC Curve,
pubmed-meshheading:12968086-Risk Factors,
pubmed-meshheading:12968086-Survival Analysis,
pubmed-meshheading:12968086-Tomography, Emission-Computed,
pubmed-meshheading:12968086-Vasodilator Agents
|
pubmed:year |
2003
|
pubmed:articleTitle |
Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.
|
pubmed:affiliation |
Regional Referral Center for Myocardial Diseases, Azienda Ospedaliera Careggi, Florence, Italy. franco.cecchi@asf.toscana.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|